{"transactions":[{"id":732282,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:54:30.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting of Stockholders of the Issuer following the date of grant, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":31675,"derivative":{"exercise_price":7.73,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":31675},"source":{"system":"sec-edgar","filing":"0001193125-26-276035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526276035/ownership.xml","form_type":"4"}},{"id":811518,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-09T20:23:54.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":7061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":7061,"derivative":{"exercise_price":24.61,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":7061},"source":{"system":"sec-edgar","filing":"0001764013-26-000044","document":"wk-form4_1775766231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000044/wk-form4_1775766231.xml","form_type":"4"}},{"id":811517,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-09T20:23:54.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":13880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":38896,"source":{"system":"sec-edgar","filing":"0001764013-26-000044","document":"wk-form4_1775766231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000044/wk-form4_1775766231.xml","form_type":"4"}},{"id":901014,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-02-18T00:56:07.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":17126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2026 annual meeting of the Issuer's stockholders or (ii) the date of the 2027 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date."}],"balance_after":17126,"derivative":{"exercise_price":27.16,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":17126},"source":{"system":"sec-edgar","filing":"0001654909-26-000001","document":"form4-02182026_120203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000165490926000001/form4-02182026_120203.xml","form_type":"4"}},{"id":1053717,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-28T20:41:23.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":138193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A fraction of the shares underlying such option equal to (x) the number of full months between April 25, 2025 (\"Vesting Commencement Date\") and the date on which a registration statement on Form S-8 is filed and effective with the Securities and Exchange Commission (the \"S-8 Filing Date\") divided by (y) 48 shall vest on the S-8 Filing Date, and 1/48th of the shares underlying such option shall vest each month thereafter on the day of the month corresponding to the Vesting Commencement Date (and if there is no suchcorresponding day for a month, then the vesting date shall be the last day of the applicable month) until 100% of the shares underlying such option is vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service the Issuer on each such vesting date."}],"balance_after":138193,"derivative":{"exercise_price":9.59,"expiration_date":"2035-08-25","underlying":"Common Stock","underlying_shares":138193},"source":{"system":"sec-edgar","filing":"0000950170-25-112008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000095017025112008/ownership.xml","form_type":"4"}},{"id":1159361,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-05T23:30:07.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":35234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Plan. The shares underlying the options will vest in three equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":35234,"derivative":{"exercise_price":15.9,"expiration_date":"2035-05-01","underlying":"Common Stock","underlying_shares":35234},"source":{"system":"sec-edgar","filing":"0001415889-25-012046","document":"form4-05052025_070503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000141588925012046/form4-05052025_070503.xml","form_type":"4"}},{"id":1159360,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T23:30:07.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":25016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in three equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":25016,"source":{"system":"sec-edgar","filing":"0001415889-25-012046","document":"form4-05052025_070503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000141588925012046/form4-05052025_070503.xml","form_type":"4"}},{"id":1276596,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-10T22:34:28.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":20491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2025 annual meeting of the Issuer's stockholders or (ii) the date of the 2026 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date."}],"balance_after":20491,"derivative":{"exercise_price":22.47,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":20491},"source":{"system":"sec-edgar","filing":"0001415889-25-003517","document":"form4-02102025_100225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588925003517/form4-02102025_100225.xml","form_type":"4"}},{"id":1633765,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-21T00:26:11.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":23364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant."}],"balance_after":23364,"derivative":{"exercise_price":14.85,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":23364},"source":{"system":"sec-edgar","filing":"0001415889-24-004484","document":"form4a-02212024_120202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924004484/form4a-02212024_120202.xml","form_type":"4/A","original_submission_date":"2024-02-15"}},{"id":1640963,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-16T01:44:19.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":16835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date."}],"balance_after":16835,"derivative":{"exercise_price":14.85,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":16835},"source":{"system":"sec-edgar","filing":"0001415889-24-004010","document":"form4-02162024_010212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000141588924004010/form4-02162024_010212.xml","form_type":"4"}},{"id":1923777,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-07T00:16:26.000Z","date":"2023-02-23","kind":"grant","planned":false,"acquired":true,"shares":27567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option will vest on March 23, 2023 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":27567,"derivative":{"exercise_price":25.28,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":27567},"source":{"system":"sec-edgar","filing":"0001209191-23-023662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000120919123023662/doc4.xml","form_type":"4"}},{"id":1990387,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-02-28T02:51:44.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":17706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 24 equal monthly installments beginning on September 24, 2022."}],"balance_after":17706,"derivative":{"exercise_price":2.48,"expiration_date":"2032-08-12","underlying":"Common Stock","underlying_shares":17706},"source":{"system":"sec-edgar","filing":"0001209191-23-013515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000120919123013515/doc4.xml","form_type":"4"}},{"id":1990386,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-28T02:51:44.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":87372,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 13, 2022 (the \"Merger Agreement\"), by and among Imara Inc. (\"Imara\"), Enliven Therapeutics, Inc., (\"Enliven\") and Iguana Merger Sub, Inc., a wholly owned subsidiary of the Issuer (the \"Merger Sub\"), provided for the merger of Merger Sub with and into Enliven, with Enliven surviving the merger as a wholly-owned subsidiary of the Imara (the \"Merger\"). At the effective time of the Merger, each share of Enliven common stock was converted into the right to receive a number of shares of Imara common stock equal to an exchange ratio of approximately 0.2951 shares of Imara common stock for each share of Enliven common stock. After completion of the Merger, the combined company will be renamed \"Enliven Therapeutics, Inc.\" and the common stock of the combined company will trade on The Nasdaq Stock Market under the symbol \"ELVN.\""}],"balance_after":87372,"source":{"system":"sec-edgar","filing":"0001209191-23-013515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000120919123013515/doc4.xml","form_type":"4"}},{"id":2972696,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-19T20:19:58.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":45193,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":70.4,"underlying":"Common Stock","underlying_shares":45193},"source":{"system":"sec-edgar","filing":"0000899243-20-031756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031756/doc4.xml","form_type":"4"}},{"id":2972695,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-19T20:19:58.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":34000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":52,"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0000899243-20-031756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031756/doc4.xml","form_type":"4"}},{"id":2972694,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-19T20:19:58.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":57400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":40.11,"underlying":"Common Stock","underlying_shares":57400},"source":{"system":"sec-edgar","filing":"0000899243-20-031756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031756/doc4.xml","form_type":"4"}},{"id":2972693,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-19T20:19:58.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":35150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":12.25,"underlying":"Common Stock","underlying_shares":35150},"source":{"system":"sec-edgar","filing":"0000899243-20-031756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031756/doc4.xml","form_type":"4"}},{"id":2972692,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-19T20:19:58.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":8748,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":9.08,"underlying":"Common Stock","underlying_shares":8748},"source":{"system":"sec-edgar","filing":"0000899243-20-031756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031756/doc4.xml","form_type":"4"}},{"id":2972691,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-19T20:19:58.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":16530,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":1.5068,"underlying":"Common Stock","underlying_shares":16530},"source":{"system":"sec-edgar","filing":"0000899243-20-031756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031756/doc4.xml","form_type":"4"}},{"id":2972690,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-11-19T20:19:58.000Z","date":"2020-11-17","kind":"other","acquired":false,"shares":90209,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 3, 2020, by and among the Issuer, Bristol-Myers Squibb Company (\"Parent\"), and Gotham Merger Sub Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 17, 2020 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $225.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the Offer Price."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 134 Shares acquired under the Issuer's Employee Stock Purchase Plan on October 31, 2020 in a transaction exempt under Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 3, 2020, by and among the Issuer, Bristol-Myers Squibb Company (\"Parent\"), and Gotham Merger Sub Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 17, 2020 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $225.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-031756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320031756/doc4.xml","form_type":"4"}},{"id":3121651,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-06-04T16:20:19.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":293,"price":50.4135,"value":14771.1555,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2013 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)."}],"balance_after":57784,"source":{"system":"sec-edgar","filing":"0000899243-20-015248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320015248/doc4.xml","form_type":"4"}},{"id":3262114,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-19T20:40:33.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":14591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2020, so that all of the underlying shares shall be vested on January 1, 2024, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2020, so that all of the underlying shares shall be vested on January 1, 2024, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2020, so that all of the underlying shares shall be vested on January 1, 2024, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":14591,"derivative":{"underlying":"Common Stock","underlying_shares":14591},"source":{"system":"sec-edgar","filing":"0000899243-20-005184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320005184/doc4.xml","form_type":"4"}},{"id":3262113,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-19T20:40:33.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":45193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly installments from January 1, 2020, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":45193,"derivative":{"exercise_price":70.4,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":45193},"source":{"system":"sec-edgar","filing":"0000899243-20-005184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320005184/doc4.xml","form_type":"4"}},{"id":3315983,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-07T17:15:11.000Z","date":"2020-01-03","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option vested and became exercisable on June 4, 2016, and the remainder vested and became exercisable in 36 equal monthly installments thereafter."}],"balance_after":6326,"derivative":{"exercise_price":1.51,"expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-20-000730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320000730/doc4.xml","form_type":"4"}},{"id":3315982,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-01-07T17:15:11.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":2466,"price":68.4511,"value":168800.4126,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover withholding taxes in connection with vesting of Restricted Stock Units reported on Form 4 filed by the Reporting Person on January 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $68.35 to $68.66 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":57491,"source":{"system":"sec-edgar","filing":"0000899243-20-000730","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320000730/doc4.xml","form_type":"4"}},{"id":3315981,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-01-07T17:15:11.000Z","date":"2020-01-03","kind":"exercise","acquired":true,"shares":10000,"price":1.51,"value":15100.0,"ownership":{"direct":true},"balance_after":59957,"source":{"system":"sec-edgar","filing":"0000899243-20-000730","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320000730/doc4.xml","form_type":"4"}},{"id":3321593,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-03T20:15:18.000Z","date":"2020-01-01","kind":"exercise","acquired":false,"shares":4950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":14850,"derivative":{"underlying":"Common Stock","underlying_shares":4950},"source":{"system":"sec-edgar","filing":"0000899243-20-000382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320000382/doc4.xml","form_type":"4"}},{"id":3321592,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2020-01-03T20:15:18.000Z","date":"2020-01-01","kind":"exercise","acquired":false,"shares":1425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":2850,"derivative":{"underlying":"Common Stock","underlying_shares":1425},"source":{"system":"sec-edgar","filing":"0000899243-20-000382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320000382/doc4.xml","form_type":"4"}},{"id":3321591,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-01-03T20:15:18.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":6375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":49957,"source":{"system":"sec-edgar","filing":"0000899243-20-000382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924320000382/doc4.xml","form_type":"4"}},{"id":3332300,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-23T21:07:09.000Z","date":"2019-12-20","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option vested in two annual installments after July 20, 2017."}],"balance_after":0,"derivative":{"exercise_price":13.9,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-19-030015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319030015/doc4.xml","form_type":"4"}},{"id":3332299,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-23T21:07:09.000Z","date":"2019-12-20","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments from January 1, 2016, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":8748,"derivative":{"exercise_price":9.08,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-030015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319030015/doc4.xml","form_type":"4"}},{"id":3332298,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-12-23T21:07:09.000Z","date":"2019-12-20","kind":"sale","acquired":false,"shares":18916,"price":70.0688,"value":1325421.4208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $70.00 to $70.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":43582,"source":{"system":"sec-edgar","filing":"0000899243-19-030015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319030015/doc4.xml","form_type":"4"}},{"id":3332297,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-12-23T21:07:09.000Z","date":"2019-12-20","kind":"exercise","acquired":true,"shares":7500,"price":13.9,"value":104250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."}],"balance_after":62498,"source":{"system":"sec-edgar","filing":"0000899243-19-030015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319030015/doc4.xml","form_type":"4"}},{"id":3332296,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-12-23T21:07:09.000Z","date":"2019-12-20","kind":"exercise","acquired":true,"shares":10000,"price":9.08,"value":90800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."}],"balance_after":54998,"source":{"system":"sec-edgar","filing":"0000899243-19-030015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319030015/doc4.xml","form_type":"4"}},{"id":3355648,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-12-02T16:10:36.000Z","date":"2019-11-29","kind":"sale","acquired":false,"shares":800,"price":66.32,"value":53056.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $66.04 to $66.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44998,"source":{"system":"sec-edgar","filing":"0000899243-19-028345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319028345/doc4.xml","form_type":"4"}},{"id":3355647,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-12-02T16:10:36.000Z","date":"2019-11-29","kind":"sale","acquired":false,"shares":7336,"price":65.52,"value":480654.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $65.00 to $65.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":45798,"source":{"system":"sec-edgar","filing":"0000899243-19-028345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319028345/doc4.xml","form_type":"4"}},{"id":3355646,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-12-02T16:10:36.000Z","date":"2019-11-27","kind":"sale","acquired":false,"shares":13096,"price":65.1326,"value":852976.5296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $65.00 to $65.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":53134,"source":{"system":"sec-edgar","filing":"0000899243-19-028345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319028345/doc4.xml","form_type":"4"}},{"id":3376156,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-11-08T19:51:11.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":162,"price":40.069,"value":6491.178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2013 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)."}],"balance_after":66230,"source":{"system":"sec-edgar","filing":"0000899243-19-027044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319027044/doc4.xml","form_type":"4"}},{"id":3406795,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-24T16:05:22.000Z","date":"2019-09-20","kind":"exercise","acquired":false,"shares":9700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments from January 1, 2017, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":40150,"derivative":{"exercise_price":12.25,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":9700},"source":{"system":"sec-edgar","filing":"0000899243-19-024147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024147/doc4.xml","form_type":"4"}},{"id":3406794,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-24T16:05:22.000Z","date":"2019-09-20","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments from January 1, 2016, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":18748,"derivative":{"exercise_price":9.08,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-024147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024147/doc4.xml","form_type":"4"}},{"id":3406793,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-09-24T16:05:22.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":19700,"price":60.0902,"value":1183776.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $60.00 to $60.27 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":66068,"source":{"system":"sec-edgar","filing":"0000899243-19-024147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024147/doc4.xml","form_type":"4"}},{"id":3406792,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-09-24T16:05:22.000Z","date":"2019-09-20","kind":"exercise","acquired":true,"shares":9700,"price":12.25,"value":118825.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."}],"balance_after":85768,"source":{"system":"sec-edgar","filing":"0000899243-19-024147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024147/doc4.xml","form_type":"4"}},{"id":3406791,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-09-24T16:05:22.000Z","date":"2019-09-20","kind":"exercise","acquired":true,"shares":10000,"price":9.08,"value":90800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."}],"balance_after":76068,"source":{"system":"sec-edgar","filing":"0000899243-19-024147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024147/doc4.xml","form_type":"4"}},{"id":3504279,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-06-03T17:48:23.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":313,"price":40.783,"value":12765.079,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2013 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)."}],"balance_after":66068,"source":{"system":"sec-edgar","filing":"0000899243-19-015396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319015396/doc4.xml","form_type":"4"}},{"id":3553321,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T20:25:00.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying the option vest in 48 equal monthly installments from January 1, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":54850,"derivative":{"exercise_price":12.25,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-19-010836","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319010836/doc4a.xml","form_type":"4/A","original_submission_date":"2018-01-03"}},{"id":3553320,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-04-17T20:25:00.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":1100,"price":43.3773,"value":47715.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $43.20 to $43.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":66777,"source":{"system":"sec-edgar","filing":"0000899243-19-010836","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319010836/doc4a.xml","form_type":"4/A","original_submission_date":"2018-01-03"}},{"id":3553319,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-04-17T20:25:00.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":3900,"price":42.7566,"value":166750.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $42.20 to $43.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":67877,"source":{"system":"sec-edgar","filing":"0000899243-19-010836","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319010836/doc4a.xml","form_type":"4/A","original_submission_date":"2018-01-03"}},{"id":3553318,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-04-17T20:25:00.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":5000,"price":12.25,"value":61250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were omitted from the Reporting Person's original Form 4, and also were omitted from the subsequent Form 4s filed by the Reporting Person through the date of this amendment"}],"balance_after":71777,"source":{"system":"sec-edgar","filing":"0000899243-19-010836","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319010836/doc4a.xml","form_type":"4/A","original_submission_date":"2018-01-03"}},{"id":3662452,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-12T16:20:37.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":19800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":19800,"derivative":{"underlying":"Common Stock","underlying_shares":19800},"source":{"system":"sec-edgar","filing":"0000899243-19-003277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319003277/doc4.xml","form_type":"4"}},{"id":3662451,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-12T16:20:37.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":57400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly  installments from January 1, 2019, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":57400,"derivative":{"exercise_price":40.11,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":57400},"source":{"system":"sec-edgar","filing":"0000899243-19-003277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319003277/doc4.xml","form_type":"4"}},{"id":3698800,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-01-09T21:21:42.000Z","date":"2019-01-07","kind":"tax_withholding","acquired":false,"shares":570,"price":42.9756,"value":24496.092,"ownership":{"direct":true},"balance_after":60755,"source":{"system":"sec-edgar","filing":"0000899243-19-000901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319000901/doc4.xml","form_type":"4"}},{"id":3707482,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-03T21:38:53.000Z","date":"2019-01-01","kind":"exercise","acquired":false,"shares":1425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":4275,"derivative":{"underlying":"Common Stock","underlying_shares":1425},"source":{"system":"sec-edgar","filing":"0000899243-19-000374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319000374/doc4.xml","form_type":"4"}},{"id":3707481,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-01-03T21:38:53.000Z","date":"2019-01-01","kind":"exercise","acquired":true,"shares":1425,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":61325,"source":{"system":"sec-edgar","filing":"0000899243-19-000374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319000374/doc4.xml","form_type":"4"}},{"id":3772282,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-11-06T19:30:55.000Z","date":"2018-11-02","kind":"sale","acquired":false,"shares":978,"price":55.45,"value":54230.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":59900,"source":{"system":"sec-edgar","filing":"0000899243-18-028347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318028347/doc4.xml","form_type":"4"}},{"id":3772281,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-11-06T19:30:55.000Z","date":"2018-10-31","kind":"grant","acquired":true,"shares":272,"price":42.16,"value":11467.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":60878,"source":{"system":"sec-edgar","filing":"0000899243-18-028347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318028347/doc4.xml","form_type":"4"}},{"id":3861324,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-25T16:17:17.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option vest and become exercisable in in two annual installments after July 20, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date."}],"balance_after":7500,"derivative":{"exercise_price":13.9,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-18-020579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318020579/doc4.xml","form_type":"4"}},{"id":3861323,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-07-25T16:17:17.000Z","date":"2018-07-23","kind":"sale","acquired":false,"shares":3101,"price":57.28,"value":177625.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $57.00 to $57.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":60606,"source":{"system":"sec-edgar","filing":"0000899243-18-020579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318020579/doc4.xml","form_type":"4"}},{"id":3861322,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-07-25T16:17:17.000Z","date":"2018-07-23","kind":"sale","acquired":false,"shares":4399,"price":56.59,"value":248939.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $56.00 to $56.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":63707,"source":{"system":"sec-edgar","filing":"0000899243-18-020579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318020579/doc4.xml","form_type":"4"}},{"id":3861321,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-07-25T16:17:17.000Z","date":"2018-07-23","kind":"exercise","acquired":true,"shares":7500,"price":13.9,"value":104250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":68106,"source":{"system":"sec-edgar","filing":"0000899243-18-020579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318020579/doc4.xml","form_type":"4"}},{"id":3943982,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-05-07T17:43:34.000Z","date":"2018-05-03","kind":"sale","acquired":false,"shares":1519,"price":48.95,"value":74355.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":60606,"source":{"system":"sec-edgar","filing":"0000899243-18-011663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318011663/doc4.xml","form_type":"4"}},{"id":3943981,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-05-07T17:43:34.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":348,"price":33.15,"value":11536.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":62125,"source":{"system":"sec-edgar","filing":"0000899243-18-011663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318011663/doc4.xml","form_type":"4"}},{"id":3964500,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-12T20:32:35.000Z","date":"2018-04-11","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest and become exercisable in 48 equal monthly installments from January 1, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":49850,"derivative":{"exercise_price":12.25,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-18-010091","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318010091/doc4.xml","form_type":"4"}},{"id":3964499,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-04-12T20:32:35.000Z","date":"2018-04-11","kind":"sale","acquired":false,"shares":5000,"price":50,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":61777,"source":{"system":"sec-edgar","filing":"0000899243-18-010091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318010091/doc4.xml","form_type":"4"}},{"id":3964498,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-04-12T20:32:35.000Z","date":"2018-04-11","kind":"exercise","acquired":true,"shares":5000,"price":12.25,"value":61250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":66777,"source":{"system":"sec-edgar","filing":"0000899243-18-010091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318010091/doc4.xml","form_type":"4"}},{"id":3980669,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-28T16:08:44.000Z","date":"2018-03-26","kind":"exercise","acquired":false,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments with the first installment on February 1, 2016, such that this option is fully exercisable on January 1, 2020."}],"balance_after":28748,"derivative":{"exercise_price":9.08,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":164},"source":{"system":"sec-edgar","filing":"0000899243-18-008700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318008700/doc4.xml","form_type":"4"}},{"id":3980668,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-28T16:08:44.000Z","date":"2018-03-26","kind":"sale","acquired":false,"shares":164,"price":50.95,"value":8355.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":61777,"source":{"system":"sec-edgar","filing":"0000899243-18-008700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318008700/doc4.xml","form_type":"4"}},{"id":3980667,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-28T16:08:44.000Z","date":"2018-03-26","kind":"exercise","acquired":true,"shares":164,"price":9.08,"value":1489.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":61941,"source":{"system":"sec-edgar","filing":"0000899243-18-008700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318008700/doc4.xml","form_type":"4"}},{"id":4026502,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-28T19:34:58.000Z","date":"2018-02-26","kind":"exercise","acquired":false,"shares":5102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments with the first installment on February 1, 2016, such that this option is fully exercisable on January 1, 2020."}],"balance_after":28912,"derivative":{"exercise_price":9.08,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":5102},"source":{"system":"sec-edgar","filing":"0000899243-18-005874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318005874/doc4.xml","form_type":"4"}},{"id":4026501,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-28T19:34:58.000Z","date":"2018-02-26","kind":"sale","acquired":false,"shares":5102,"price":60,"value":306120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":61777,"source":{"system":"sec-edgar","filing":"0000899243-18-005874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318005874/doc4.xml","form_type":"4"}},{"id":4026500,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-28T19:34:58.000Z","date":"2018-02-26","kind":"exercise","acquired":true,"shares":5102,"price":9.08,"value":46326.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":66879,"source":{"system":"sec-edgar","filing":"0000899243-18-005874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318005874/doc4.xml","form_type":"4"}},{"id":4054251,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-15T20:27:52.000Z","date":"2018-01-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest in 48 equal monthly installments from January 1, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":54850,"derivative":{"exercise_price":12.25,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-18-004341","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318004341/doc4a.xml","form_type":"4/A","original_submission_date":"2018-01-10"}},{"id":4054250,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-15T20:27:52.000Z","date":"2018-01-09","kind":"sale","acquired":false,"shares":5000,"price":45,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":61777,"source":{"system":"sec-edgar","filing":"0000899243-18-004341","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318004341/doc4a.xml","form_type":"4/A","original_submission_date":"2018-01-10"}},{"id":4054249,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-15T20:27:52.000Z","date":"2018-01-09","kind":"exercise","acquired":true,"shares":5000,"price":12.25,"value":61250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":66777,"source":{"system":"sec-edgar","filing":"0000899243-18-004341","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318004341/doc4a.xml","form_type":"4/A","original_submission_date":"2018-01-10"}},{"id":4095700,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-01-18T19:57:10.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":5700,"derivative":{"underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0000899243-18-001383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318001383/doc4.xml","form_type":"4"}},{"id":4095699,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T19:57:10.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly  installments from January 1, 2018, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":34000,"derivative":{"exercise_price":52,"expiration_date":"2028-01-15","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0000899243-18-001383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318001383/doc4.xml","form_type":"4"}},{"id":4101830,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-10T16:45:46.000Z","date":"2018-01-09","kind":"sale","acquired":false,"shares":5000,"price":45,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":56777,"source":{"system":"sec-edgar","filing":"0000899243-18-000872","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318000872/doc4.xml","form_type":"4"}},{"id":4110468,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-03T20:06:20.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":1100,"price":43.3773,"value":47715.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $43.20 to $43.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":61777,"source":{"system":"sec-edgar","filing":"0000899243-18-000380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318000380/doc4.xml","form_type":"4"}},{"id":4110467,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-03T20:06:20.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":3900,"price":42.7566,"value":166750.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $42.20 to $43.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":62877,"source":{"system":"sec-edgar","filing":"0000899243-18-000380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318000380/doc4.xml","form_type":"4"}},{"id":4172359,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-11-03T19:45:38.000Z","date":"2017-10-31","kind":"grant","acquired":true,"shares":1232,"price":11.56,"value":14241.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":66777,"source":{"system":"sec-edgar","filing":"0000899243-17-025395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317025395/doc4.xml","form_type":"4"}},{"id":4238597,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-08-09T17:15:35.000Z","date":"2017-08-07","kind":"sale","acquired":false,"shares":10000,"price":30,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":65545,"source":{"system":"sec-edgar","filing":"0000899243-17-019942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317019942/doc4.xml","form_type":"4"}},{"id":4238596,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-08-09T17:15:35.000Z","date":"2017-08-07","kind":"sale","acquired":false,"shares":5000,"price":25,"value":125000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":75545,"source":{"system":"sec-edgar","filing":"0000899243-17-019942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317019942/doc4.xml","form_type":"4"}},{"id":4249890,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-07-27T17:11:17.000Z","date":"2017-07-25","kind":"sale","acquired":false,"shares":4333,"price":15.015,"value":65059.995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $15.00 to $15.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":80545,"source":{"system":"sec-edgar","filing":"0000899243-17-019194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317019194/doc4.xml","form_type":"4"}},{"id":4252420,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-24T16:05:23.000Z","date":"2017-07-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in two annual installments after the date of grant.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":13.9,"expiration_date":"2027-07-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-17-018752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317018752/doc4.xml","form_type":"4"}},{"id":4317768,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-05-16T13:49:21.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":978,"price":11.0925,"value":10848.465,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":84878,"source":{"system":"sec-edgar","filing":"0000899243-17-013323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317013323/doc4.xml","form_type":"4"}},{"id":4371277,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-27T17:30:55.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":5102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 4, 2015, the Reporting Person was granted an option to purchase 20,408 shares of Common Stock under the issuer's 2012 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On March 23, 2017, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 5,102 of the shares underlying such option."}],"balance_after":10204,"derivative":{"exercise_price":1.51,"exercise_date":"2017-03-23","expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":5102},"source":{"system":"sec-edgar","filing":"0000899243-17-008656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317008656/doc4.xml","form_type":"4"}},{"id":4374330,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-03-22T20:37:31.000Z","date":"2017-03-20","kind":"sale","acquired":false,"shares":667,"price":15,"value":10005.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":83900,"source":{"system":"sec-edgar","filing":"0000899243-17-008435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317008435/doc4.xml","form_type":"4"}},{"id":4484999,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-20T17:41:44.000Z","date":"2017-01-18","kind":"grant","acquired":true,"shares":59850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly  installments from January 1, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":59850,"derivative":{"exercise_price":12.25,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":59850},"source":{"system":"sec-edgar","filing":"0000899243-17-001671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317001671/doc4.xml","form_type":"4"}},{"id":4569113,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-02T17:41:13.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":5102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 4, 2015, the Reporting Person was granted an option to purchase 20,408 shares of Common Stock under the issuer's 2012 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On November 1, 2016, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 5,102 of the shares underlying such option."}],"balance_after":5102,"derivative":{"exercise_price":1.51,"exercise_date":"2016-11-01","expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":5102},"source":{"system":"sec-edgar","filing":"0000899243-16-032643","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924316032643/doc4.xml","form_type":"4"}},{"id":4569112,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36849,"kind":"person","name":"Bauer Jake","position":1,"cik":"0001654909","reported_name":"Bauer Jake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-11-02T17:41:13.000Z","date":"2016-10-31","kind":"grant","acquired":true,"shares":1519,"price":10.03,"value":15235.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":84567,"source":{"system":"sec-edgar","filing":"0000899243-16-032643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924316032643/doc4.xml","form_type":"4"}}]}